Dimension Biomedical
Developer of 3D-printed orthopedic implants including titanium alloy, PEEK, and biodegradable products for spinal and bone reconstruction surgery.
- CEO / Founder
- 伍苏华 (Wu Suhua)
- Team Size
- 51-200
- Stage
- Growth Stage
- Latest Round
- Series A
- Key Investors
- 西高投 (Xi'an High-tech Venture Capital); 淄博裕泰创业投资合伙企业 (Zibo Yutai Venture Capital); 陕西景瀚 (Shaanxi Jinghan); 帝煌资本 (Dihuang Capital); 西安高新新兴产业投资基金
Technology & Products
Key Products
WedoCage™ Hydroxyapatite-Coated Porous Titanium Interbody Fusion Cage (NMPA Class III, 2023); SLM Patient-Matched Thoracolumbar Artificial Vertebral Body (NMPA Class III, 2023); 3D-Printed PEEK Patient-Matched Chest/Rib Prosthesis (Innovation Device Special Review, 2026); 3D-Printed Self-Stabilizing Cervical Interbody Fusion Cage System; Additively Manufactured Proximal Humerus Anatomical Intramedullary Support Prosthesis System; 3D-Printed Simulation Reconstruction Fusion Series
Technological Advantage
Proprietary vacuum plasma spraying technology for HA coating on 3D-printed porous titanium; truss+microporous structure design for optimal elastic modulus matching; SLM (PBF-LB) process expertise; 3,800 sqm GMP workshop with advanced laser melting equipment; 26 national invention patents; 200+ SCI publications.
Differentiation
Value Proposition
Bioactive-coated 3D-printed titanium alloy orthopedic implants with HA coating that eliminates need for additional bone grafting, achieving 97% fusion efficacy in clinical trials with superior biomechanical properties.
How They Differentiate
Commercialized a bioactive HA-coated 3D-printed porous titanium implant (WedoCage™) that achieves 97% fusion efficacy without additional bone grafting; strong academic ties with Air Force Medical University; 26+ patents; participated in national "13th Five-Year" and "14th Five-Year" key R&D programs.
Market & Competition
Target Customers
Hospitals and surgical centers (orthopedic/spinal surgery departments); patients requiring spinal fusion, bone tumor reconstruction, and chest wall reconstruction.
Industry Verticals
Orthopedic Surgery; Spinal Surgery; Bone Tumor Reconstruction; Thoracic Surgery
Competitors
爱康医疗 (AK Medical) - listed HKEX, 3D-printed orthopedic implants; 大博医疗 (Double Medical) - 3D-printed PEEK interbody fusion cages; 嘉思特 (JUST) - 3D-printed orthopedic implants
Growth & Milestones
Major Milestones
2014: World's first 3D-printed clavicle and scapula titanium alloy prosthesis (team led by Prof. Guo Zheng, pre-company); 2017: Company founded; 2017: Approved for National Key R&D Program; 2022: Selected for MIIT's first batch of Additive Manufacturing Typical Application Scenarios; 2023-09: WedoCage™ HA-coated porous titanium interbody cage received NMPA Class III certification (global-first bioactive-coated 3D-printed titanium implant); 2024: Global-first additively manufactured proximal humerus anatomical intramedullary support product launched; 2024: Selected as Xi'an High-tech Zone Key Technology Commercialization Project; 2026: 3D-printed PEEK patient-matched chest/rib prosthesis entered NMPA Innovation Device Special Review; 2026: Received Shaanxi Provincial Science and Technology Progress Award First Prize.
Notable Customers
Air Force Medical University Tangdu Hospital; Army Medical University; Jilin University affiliated hospitals (multi-center clinical trial sites)